Australia's innovation problem: commercialisation, not capital
Australia does not have a funding problem. It has a commercialisation problem. New research argues the federal government's innovation programs are requiring service providers to use frameworks that empirical evidence links to failure, not success. Technology Readiness Levels, Lean methodology, Business Model Canvas: all mandated in some contracts, all incomplete oversimplifications. The numbers tell the story. Australia's R&D intensity: 1.69% of GDP in 2023–24, down from 2.24% in 2008–09. More than 90% of granted patents never reach commercial outcomes. As many as 90% of technology-based startups fail. An estimated 95% of researchers' efforts to translate work into commercial outcomes fail. These are not edge cases. This is the norm. The Ambitious Australia report correctly identifies research translation as central to economic future. But it risks treating the research system as if it were the innovation system. Different problems, different solutions. For sales teams selling into innovation infrastructure: universities, R&D-heavy SMEs, accelerators, government agencies, enterprise software vendors supporting commercialisation, this is market context. The addressable market is constrained by smaller average company size, modest corporate R&D spend, heavy dependence on public funding and grants. That means longer sales cycles, more procurement-driven purchasing than US or EU markets. The policy environment has many separate programs and funds. Commentators argue the mission is fragmented, incentives poorly aligned. The bottleneck is not capital availability. It is commercialisation, procurement, scale-up pathways, industry-research collaboration. Patents filed, startups launched, funding raised: these metrics measure activity, not outcomes. Policy designed around poor metrics produces more of what the metrics measure, not more of what matters. Australia will never compete with China, Europe, or the US on total funding dollars. Without fixing the commercialisation pathway, the most competitive innovations will follow the money overseas. That is not a capital problem. That is a systems problem.